
    
      Previous studies on cancer pain lacked assessment of quality of life. And most of previous
      studies on cancer pain did not give attention to symptoms accompanied with pain. We include
      such variables as outcome measures, and aimed to evaluate the efficacy and the safety of
      intravenous caffeine in advanced cancer inpatients.
    
  